特集 循環器系薬剤のトレンド２
β 遮 断 薬（経口薬）
2014 年 73 巻 1 号 p. 20-21
詳細
2014 年 73 巻 1 号 p. 20-21
The effectiveness of β-blockers in the management of chronic heart failure has been widely validated. Patients with simple hypertension are not good candidates for β-blockers. β-blockers should be used for complicated cardiovascular diseases, including coronary artery disease, heart failure, and arrhythmia.
